Nine Pharma Private Limited
About Nine Pharma Private Limited
Data last updated:
Nine Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2007PTC168889.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suraj Shivaji Diwekar and Shivaji Kerba Diwekar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No. 6 Raj Nagar Shahnoor Wadi, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2021, the company reported a revenue of ₹50,000. For the same year it recorded a net loss of ₹2.86 Lakh and EBITDA of -₹2.86 Lakh.
Company details
Contact details
Nine Pharma Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressPlot No. 6 Raj Nagar Shahnoor Wadi, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nine Pharma Private Limited
FY 2021 filings availableNine Pharma Private Limited reported revenue of ₹50,000 for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nine Pharma Private Limited, buy the company report.
Board of directors of Nine Pharma Private Limited
Nine Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivaji Kerba Diwekar Also directs: Des Engineering & Systems Private Limited | Additional Director | 14 May 2022 | 4 Years 5 Months | Current |
| Suraj Shivaji Diwekar Also directs: Des Engineering & Systems Private Limited | Director | 09 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Nine Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Authentica Botanicals Private Limited | ₹50,615 (FY 2025) | 58.0% | Sri Ganganagar, Rajasthan, India | |||
| Indosol Drugs Limited | ₹50,220 (FY 2025) | -97.0% | Mumbai, Maharashtra, India | |||
| Panlocus Microlife Private Limited | ₹50,058 (FY 2025) | 21.0% | Bangalore, Karnataka, India | |||
| Nine Pharma Private Limitedthis company | ₹50,000 (FY 2021) | -₹2.86 Lakh | Aurangabad, Maharashtra, India | |||
| Kneel Pharmaceuticals Private Limited | ₹50,000 (FY 2024) | Delhi, India | ||||
| Sattva Pharmaceuticals Private Limited | ₹50,000 (FY 2025) | -29.0% | Mumbai, Maharashtra, India | |||
| Astrozen Pharmaceuticals Private Limited | ₹49,914 (FY 2022) | 15.0% | Thane, Maharashtra, India | |||
| Devbhoomi Pharmaceuticals Private Limited | ₹49,900 (FY 2024) | 55.0% | New Delhi, Delhi, India | |||
| Adven Lifecare Private Limited | ₹49,780 (FY 2025) | 36.0% | Gurugram, Haryana, India | |||
| Seasons Biologicals Private Limited | ₹49,010 (FY 2025) | Hyderabad, Telangana, India | ||||
| Nectar Lifestyles Private Limited | ₹48,570 (FY 2018) | New Delhi, Delhi, India |
To see the full peer comparison of Nine Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nine Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nine Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nine Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nine Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Ashok Narwade ceased to be Director on 27 May 2022.
Frequently asked questions
Nine Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2007 (19+ years old) and is registered under CIN U24239MH2007PTC168889.
Nine Pharma has 2 current directors:
- Shivaji Kerba Diwekar - Additional Director
- Suraj Shivaji Diwekar - Director
The latest financial statements of Nine Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nine Pharma is U24239MH2007PTC168889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nine Pharma was incorporated on 16 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nine Pharma by revenue are Authentica Botanicals Private Limited, Indosol Drugs Limited, Panlocus Microlife Private Limited, Kneel Pharmaceuticals Private Limited, Sattva Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Ashok Narwade ceased to be Director on 27 May 2022. Shivaji Kerba Diwekar was appointed as Additional Director on 14 May 2022. Suraj Shivaji Diwekar was appointed as Director on 09 Apr 2021.
The registered office of Nine Pharma is at Plot No. 6 Raj Nagar Shahnoor Wadi, Aurangabad, Maharashtra, India – 431001.
Nine Pharma operates in the pharma industry, in the drug formulation and development segment.
Nine Pharma can be reached at its registered office: Plot No. 6 Raj Nagar Shahnoor Wadi, Aurangabad, Maharashtra, India – 431001.
Nine Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.